George Chen, MBA, MD

SHanghai, China
George Chen, MD, Chairman and CEO of D3 Bio, is an oncologist by training with a successful track record in the world of global pharmaceutical companies. Prior to founding D3 Bio, he held senior global positions in research, drug development and management at leading institutions, such as the National Institutes of Health, and multinational pharmaceutical companies, such as Eli Lilly, GlaxoSmithKline, Johnson & Johnson and Astra Zeneca. At these organizations he led development and regulatory registrations of blockbuster drugs into the U.S. and Chinese markets, directing more than 70 IND approvals and more than 30 NDAs. His medical degree is from the Shanghai Medical College of Fudan University and his MBA is from the Wharton School of Business at the University of Pennsylvania.
Speaking In
3:00 PM - 4:00 PM (EST)
Tuesday, February 16
Recent deal announcements are giving evidence to Chinese companies being at the heels of their…